Skip to main content
SpringerLink
Log in

Prediction and prevention of type 1 diabetes

  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

Abstract

The incidence of type 1 diabetes continues to increase worldwide. Despite major strides in the daily care of patients with the disease, the patients’ contribution to overall morbidity and mortality statistics and health care economic burden to society is disproportionately large because of the high rate of microvascular and macrovascular complications. The quest for prevention of type 1 diabetes has been made feasible by the unraveling of the immunogenetics of the disease and the identification of at-risk subjects by an enhanced understanding of the natural history of the prediabetic period. A combination of immunologic, metabolic, and genetic markers can be used to accurately predict the disease in higher-risk relatives and the general population. This has enabled initiation of worldwide trials (Diabetes Prevention Trial-Type 1, European Nicotinamide Diabetes Intervention Trial, and Trial to Prevent Diabetes in Genetically at Risk) aimed at the prevention of the disease. Various promising agents are being considered for use in different at-risk populations in the near future.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Tuomilehto J: Finland: highest incidence of childhood diabetes. Diabetes Voice 1999, 4:30–33.

    Google Scholar 

  2. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993, 329:977–986.

    Article  Google Scholar 

  3. Leslie RDG, Elliot RB: Early environmental events as a cause of IDDM: evidence and implications. Diabetes 1994, 43:843–850.

    Article  PubMed  CAS  Google Scholar 

  4. Gamble DR: The epidemiology of insulin dependent diabetes, with particular reference to the relationship of virus infection to its etiology. Epidemiol Rev 1980, 2:49–69.

    PubMed  CAS  Google Scholar 

  5. Lorenzen T, Pociot F, Hougaard P, Neruo J: Long-term risk of IDDM in first degree relatives of patients with IDDM. Diabetologia 1994, 37:321–327.

    Article  PubMed  CAS  Google Scholar 

  6. Ziegler AG, Hummel M, Schenker M, Bonifacio E: Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes 1999, 48:460–468. This study demonstrates that almost 10% of offspring of type 1 parents develop islet-related autoantibodies in the first 2 years of life. This is important for the study of the natural history and immunopathogenesis of type 1 diabetes.

    Article  PubMed  CAS  Google Scholar 

  7. Atkinson MA, Bowman MA, Campbell L, et al.: Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. J Clin Invest 1994, 94:2125–2129.

    PubMed  CAS  Google Scholar 

  8. Karounos DG, Molinsky JS, Thomas JW: Monoclonal antibody to rubella virus capsid protein recognizes a beta cell antigen. J Immunol 1993, 150:3080–3085.

    PubMed  CAS  Google Scholar 

  9. Karjalainen J, Martin JM, Knip M, et al.: A bovine albumin peptide as a possible trigger of insulin-dependent diabetes mellitus. N Engl J Med 1992, 327:302–307.

    Article  PubMed  CAS  Google Scholar 

  10. Classen J: The timing of immunization affects the development of diabetes in rodents. Autoimmunity 1996, 24:137–145.

    PubMed  CAS  Google Scholar 

  11. She JX: Genetic factors in type 1 diabetes: a complex disease. J Clin Ligand Assay 1998, 21:272–281. This is an outstanding review of the genetics of type 1 diabetes.

    Google Scholar 

  12. Krischer JP, Schatz D, Riley WJ, et al.: Insulin and islet cell autoantibodies as time dependent covariates in the development of insulin dependent diabetes: a prospective study in relatives. J Clin Endocrinol Metab 1993, 77:743–749.

    Article  PubMed  CAS  Google Scholar 

  13. Riley WJ, Maclaren NK, Krischer JP, et al.: A Prospective study of the development of diabetes in relatives of patients with insulin dependent diabetes. N Engl J Med 1990, 323:1167–1172.

    Article  PubMed  CAS  Google Scholar 

  14. Maclaren N, Lan M: Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2b predict immune mediated (type 1) diabetes in relatives. J Autoimmun 1999, 12:279–287. This article reviews the prediction of type 1 diabetes using panels of islet-related autoantibodies.

    Article  PubMed  CAS  Google Scholar 

  15. Zavialov A, Ankelo M, Hinkkanen A: Novel fusion proteins in the analysis of diabetes-associated autoantibodies to GAD65 and IA-2. J Immunol Methods 2000, 246:91–96.

    Article  PubMed  CAS  Google Scholar 

  16. Litherland SA, Xie XT, Hutson AD, et al.: Aberrant prostaglandin synthetase 2 expression defines an antigen-presenting cell defect for insulin-dependent diabetes mellitus. J Clin Invest 1999, 104:515–523. This study suggests a potentially new cell-mediated marker for type 1 diabetes.

    Article  PubMed  CAS  Google Scholar 

  17. Thai AC, Eisenbarth GS: Natural history of IDDM. Diabetes Rev 1993, 1:1–14.

    Google Scholar 

  18. DPT-1 Study Group: The Diabetes Prevention Trial-type 1 diabetes (DPT-1). Diabetes 1994, 43(suppl):159A.

    Google Scholar 

  19. Muir A, Schatz D, Maclaren NK: Antigen specific immunotherapy: oral tolerance and subcutaneous immunization in the treatment of insulin-dependent diabetes. Diabetes Metab Rev 1993, 9:279–287.

    PubMed  CAS  Google Scholar 

  20. Zhang I, Davidson L, Eisenbarth G, Weiner HL: Suppression of diabetes in non-obese diabetic mice by oral administration of porcine insulin. Proc Natl Acad Sci U S A 1991, 88:10252–10256.

    Article  PubMed  CAS  Google Scholar 

  21. Weiner HL, Mackin GA, Matsui M, et al.: Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science 1993, 259:1321–1324.

    Article  PubMed  CAS  Google Scholar 

  22. Trentham DE, Dysnesius-Trentham RA, Orav EJ, et al.: Effects of oral administration of type II collagen on rheumatoid arthritis. Science 1993, 261:1727–1730.

    Article  PubMed  CAS  Google Scholar 

  23. Pozzilli P, Pitocco D, Cavallo MG, et al.: No effect of oral insulin on residual beta-cell function in recent onset type 1 diabetes (the IMDIAB VII). Diabetologia 2000, 43:1000–1004.

    Article  PubMed  CAS  Google Scholar 

  24. Chaillous L, Lefevre H, Thivolet C, et al.: Oral insulin administration and residual b-cell function in recent-onset type 1 diabetes: a multicenter randomised controlled trial. Lancet 2000, 356:545–549.

    Article  PubMed  CAS  Google Scholar 

  25. Pozzilli P, Andreani D: The potential role of nicotinamide in the secondary prevention of IDDM. Diabetes Metab Rev 1993, 9:219–230.

    Article  PubMed  CAS  Google Scholar 

  26. Kolb H, Burkert V: Nicotinamide in type 1 diabetes. Diabetes Care 1999, 22:B16-B20.

    PubMed  Google Scholar 

  27. Gerstein HC: Cow’s milk exposure and type I diabetes mellitus: a critical overview of the clinical literature. Diabetes Care 1994, 17:13–19.

    Article  PubMed  CAS  Google Scholar 

  28. Atkinson MA, Bowman MA, Kao KJ, et al.: Lack of immune responsiveness to bovine serum albumin in insulindependent diabetes. N Engl J Med 1993, 329:1853–1858.

    Article  PubMed  CAS  Google Scholar 

  29. Harrison L, Honeyman M, Steel C, et al.: Intranasal insulin trial in preclinical type 1 diabetes. Diabetes 1999, 48(suppl 1):A206.

    Google Scholar 

  30. Simell T, Hahl J, Kupila, et al.: Direct costs of type 1 diabetes prevention based on nasal insulin: a simulation model for the DIPP project. Diabetes 1999, 48(suppl 1):A211.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, University of Florida, Box 100296 JHMHC, 32610, Gainesville, FL, USA

    Alba E. Morales MD, Jing Xiong She PhD & Desmond A. Schatz MD

Authors
  1. Alba E. Morales MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jing Xiong She PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Desmond A. Schatz MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Morales, A.E., She, J.X. & Schatz, D.A. Prediction and prevention of type 1 diabetes. Curr Diab Rep 1, 28–32 (2001). https://doi.org/10.1007/s11892-001-0007-9

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11892-001-0007-9

Keywords

Search

Navigation